News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
239,908 Results
Type
Article (5581)
Company Profile (25)
Press Release (234302)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (84380)
Career Advice (465)
Deals (15502)
Drug Delivery (10)
Drug Development (20111)
Employer Resources (30)
FDA (3800)
Job Trends (4028)
News (123999)
Policy (7958)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (328)
Accelerated approval (6)
Adcomms (4)
Allergies (16)
Alliances (15831)
ALS (38)
Alzheimer's disease (301)
Antibody-drug conjugate (ADC) (75)
Approvals (3941)
Artificial intelligence (95)
Autoimmune disease (41)
Automation (6)
Bankruptcy (98)
Best Places to Work (2965)
BIOSECURE Act (1)
Biosimilars (39)
Biotechnology (24)
Bladder cancer (35)
Brain cancer (7)
Breast cancer (112)
Cancer (1091)
Cardiovascular disease (73)
Career advice (397)
Career pathing (3)
CAR-T (73)
CDC (2)
Cell therapy (188)
Cervical cancer (8)
Clinical research (17722)
Collaboration (447)
Compensation (374)
Complete response letters (8)
COVID-19 (355)
CRISPR (17)
C-suite (347)
Cystic fibrosis (28)
Data (1497)
Denatured (1)
Depression (22)
Diabetes (92)
Diagnostics (2183)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (38)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (38)
Earnings (43178)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (40315)
Executive appointments (432)
FDA (4622)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (364)
Gene editing (38)
Generative AI (8)
Gene therapy (113)
GLP-1 (172)
Government (467)
Guidances (198)
Healthcare (5280)
HIV (11)
Huntington's disease (6)
IgA nephropathy (15)
Immunology and inflammation (42)
Immuno-oncology (13)
Indications (17)
Infectious disease (383)
Inflammatory bowel disease (39)
Inflation Reduction Act (3)
Influenza (7)
Intellectual property (38)
Interviews (53)
IPO (8062)
IRA (3)
Job creations (1147)
Job search strategy (363)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (110)
Leadership (5)
Legal (2380)
Liver cancer (25)
Longevity (2)
Lung cancer (159)
Lymphoma (96)
Machine learning (3)
Management (10)
Manufacturing (156)
MASH (54)
Medical device (4033)
Medtech (4043)
Mergers & acquisitions (7860)
Metabolic disorders (249)
Multiple sclerosis (22)
NASH (6)
Neurodegenerative disease (56)
Neuropsychiatric disorders (12)
Neuroscience (564)
NextGen: Class of 2026 (1722)
Non-profit (742)
Now hiring (5)
Obesity (100)
Opinion (33)
Ovarian cancer (28)
Pain (30)
Pancreatic cancer (42)
Parkinson's disease (54)
Partnered (6)
Patents (59)
Patient recruitment (122)
Peanut (6)
People (25639)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (5399)
Phase 2 (7624)
Phase 3 (6149)
Pipeline (2084)
Policy (19)
Postmarket research (628)
Preclinical (2041)
Press Release (66)
Prostate cancer (60)
Psychedelics (3)
Radiopharmaceuticals (112)
Rare diseases (187)
Real estate (2121)
Recruiting (8)
Regulatory (6027)
Reports (17)
Research institute (336)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (53)
Series A (59)
Series B (59)
Sickle cell disease (11)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1095)
Stomach cancer (2)
Supply chain (13)
Tariffs (9)
The Weekly (1)
Vaccines (90)
Venture capital (12)
Weight loss (38)
Women's health (7)
Date
Today (31)
Last 7 days (188)
Last 30 days (574)
Last 365 days (9449)
2026 (941)
2025 (9552)
2024 (11590)
2023 (13958)
2022 (19495)
2021 (20510)
2020 (18900)
2019 (13709)
2018 (10548)
2017 (10339)
2016 (9432)
2015 (12422)
2014 (9822)
2013 (7939)
2012 (8587)
2011 (9052)
2010 (8796)
Location
Africa (192)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (16686)
Australia (1747)
California (3643)
Canada (1148)
China (650)
Colorado (145)
Connecticut (165)
Delaware (72)
Europe (26403)
Florida (551)
Georgia (69)
Idaho (24)
Illinois (166)
India (17)
Indiana (110)
Iowa (9)
Japan (171)
Kansas (37)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (373)
Massachusetts (2937)
Michigan (104)
Minnesota (203)
Mississippi (1)
Missouri (33)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1088)
New Mexico (5)
New York (891)
North Carolina (498)
North Dakota (4)
Northern California (1925)
Ohio (118)
Oklahoma (5)
Oregon (6)
Pennsylvania (638)
Puerto Rico (2)
Rhode Island (19)
South America (286)
South Carolina (17)
Southern California (1333)
Tennessee (68)
Texas (496)
United States (12842)
Utah (111)
Virginia (85)
Washington D.C. (17)
Washington State (300)
West Virginia (2)
Wisconsin (58)
Wyoming (1)
239,908 Results for "generon shanghai corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ProImmune Introduces Mastering Immunity 2026 - Shanghai Symposium to Address Key Immunogenicity Challenges
January 21, 2026
·
2 min read
Press Releases
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
February 5, 2026
·
6 min read
Press Releases
RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria
October 21, 2025
·
9 min read
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
Press Releases
InGeneron, Inc. Announces EU Quality Management System Certificate Under MDR Regulation (EU) 2017/745 for Medical Devices
February 5, 2026
·
2 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
SNS812, an innovative siRNA drug from Oneness and Microbio (Shanghai), selected for ATS 2025 oral presentation, demonstrating world-leading clinical outcomes in COVID-19 treatment
May 19, 2025
·
3 min read
GenSci Launches Global Innovation Hub in Shanghai
Changchun GeneScience Pharmaceutical, a subsidiary of Changchun High-Tech Industries, held a groundbreaking ceremony for its new global headquarters and research & development center at Shanghai Zhangjiang International Medical Park on December 15th.
December 23, 2023
·
7 min read
Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis
Shanghai Argo Biopharmaceutical Co., Ltd. announced that it has entered into two exclusive license and collaboration agreements with Novartis PHARMA AG.
January 7, 2024
·
3 min read
MDimune Inc. broadens its global footprint with residency at JLABS @ Shanghai
MDimune Inc. announced today that it took up residence at Johnson & Johnson Innovation – JLABS @ Shanghai (‘JLABS’), located in Shanghai, China, starting in September.
October 5, 2023
·
1 min read
1 of 23,991
Next
